Literature DB >> 19114701

Colorectal cancer risk prediction tool for white men and women without known susceptibility.

Andrew N Freedman1, Martha L Slattery, Rachel Ballard-Barbash, Gordon Willis, Bette J Cann, David Pee, Mitchell H Gail, Ruth M Pfeiffer.   

Abstract

PURPOSE: Given the high incidence of colorectal cancer (CRC), and the availability of procedures that can detect disease and remove precancerous lesions, there is a need for a model that estimates the probability of developing CRC across various age intervals and risk factor profiles.
METHODS: The development of separate CRC absolute risk models for men and women included estimating relative risks and attributable risk parameters from population-based case-control data separately for proximal, distal, and rectal cancer and combining these estimates with baseline age-specific cancer hazard rates based on Surveillance, Epidemiology, and End Results (SEER) incidence rates and competing mortality risks.
RESULTS: For men, the model included a cancer-negative sigmoidoscopy/colonoscopy in the last 10 years, polyp history in the last 10 years, history of CRC in first-degree relatives, aspirin and nonsteroidal anti-inflammatory drug (NSAID) use, cigarette smoking, body mass index (BMI), current leisure-time vigorous activity, and vegetable consumption. For women, the model included sigmoidoscopy/colonoscopy, polyp history, history of CRC in first-degree relatives, aspirin and NSAID use, BMI, leisure-time vigorous activity, vegetable consumption, hormone-replacement therapy (HRT), and estrogen exposure on the basis of menopausal status. For men and women, relative risks differed slightly by tumor site. A validation study in independent data indicates that the models for men and women are well calibrated.
CONCLUSION: We developed absolute risk prediction models for CRC from population-based data, and a simple questionnaire suitable for self-administration. This model is potentially useful for counseling, for designing research intervention studies, and for other applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114701      PMCID: PMC2645090          DOI: 10.1200/JCO.2008.17.4797

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  38 in total

1.  The role of measurement error in estimating levels of physical activity.

Authors:  Pietro Ferrari; Christine Friedenreich; Charles E Matthews
Journal:  Am J Epidemiol       Date:  2007-08-01       Impact factor: 4.897

2.  Standard errors for attributable risk for simple and complex sample designs.

Authors:  Barry I Graubard; Thomas R Fears
Journal:  Biometrics       Date:  2005-09       Impact factor: 2.571

3.  Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.

Authors:  Thomas R Fears; DuPont Guerry; Ruth M Pfeiffer; Richard W Sagebiel; David E Elder; Allan Halpern; Elizabeth A Holly; Patricia Hartge; Margaret A Tucker
Journal:  J Clin Oncol       Date:  2006-05-25       Impact factor: 44.544

4.  A risk model for prediction of lung cancer.

Authors:  Margaret R Spitz; Waun Ki Hong; Christopher I Amos; Xifeng Wu; Matthew B Schabath; Qiong Dong; Sanjay Shete; Carol J Etzel
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

Review 5.  Colorectal cancer: molecules and populations.

Authors:  J D Potter
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

6.  Cancer risk prediction models: a workshop on development, evaluation, and application.

Authors:  Andrew N Freedman; Daniela Seminara; Mitchell H Gail; Patricia Hartge; Graham A Colditz; Rachel Ballard-Barbash; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

Review 7.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.

Authors:  Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'Brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

8.  Physical activity and colon cancer: a public health perspective.

Authors:  M L Slattery; S L Edwards; K N Ma; G D Friedman; J D Potter
Journal:  Ann Epidemiol       Date:  1997-02       Impact factor: 3.797

9.  Projecting individualized probabilities of developing bladder cancer in white individuals.

Authors:  Xifeng Wu; Jie Lin; H Barton Grossman; Maosheng Huang; Jian Gu; Carol J Etzel; Christopher I Amos; Colin P Dinney; Margaret R Spitz
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

10.  Development of a risk score for colorectal cancer in men.

Authors:  Jane A Driver; J Michael Gaziano; Rebecca P Gelber; I-Min Lee; Julie E Buring; Tobias Kurth
Journal:  Am J Med       Date:  2007-03       Impact factor: 4.965

View more
  105 in total

1.  JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Susan A Kadlubar; Kristina L Bondurant; Roger K Wolff
Journal:  Mol Carcinog       Date:  2011-11-28       Impact factor: 4.784

2.  Effects of personalized colorectal cancer risk information on laypersons' interest in colorectal cancer screening: The importance of individual differences.

Authors:  Paul K J Han; Christine W Duarte; Susannah Daggett; Andrea Siewers; Bill Killam; Kahsi A Smith; Andrew N Freedman
Journal:  Patient Educ Couns       Date:  2015-07-19

3.  Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and gender.

Authors:  Mart Dela Cruz; Ramesh K Wali; Laura K Bianchi; Andrew J Radosevich; Susan E Crawford; Lisa Jepeal; Michael J Goldberg; Jaclyn Weinstein; Navneet Momi; Priya Roy; Audrey H Calderwood; Vadim Backman; Hemant K Roy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-25       Impact factor: 4.254

4.  Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study.

Authors:  Brian J Wells; Michael W Kattan; Gregory S Cooper; Leila Jackson; Siran Koroukian
Journal:  J Am Board Fam Med       Date:  2014 Jan-Feb       Impact factor: 2.657

Review 5.  Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

6.  Different risk factors for advanced colorectal neoplasm in young adults.

Authors:  Ji Yeon Kim; Yoon Suk Jung; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Kyu Yong Choi; Dong Il Park
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

7.  Impact of Age on the Risk of Advanced Colorectal Neoplasia in a Young Population: An Analysis Using the Predicted Probability Model.

Authors:  Yoon Suk Jung; Chan Hyuk Park; Nam Hee Kim; Mi Yeon Lee; Dong Il Park
Journal:  Dig Dis Sci       Date:  2017-07-21       Impact factor: 3.199

8.  Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.

Authors:  Stephanie R Land; Qing Liu; D Lawrence Wickerham; Joseph P Costantino; Patricia A Ganz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-25       Impact factor: 4.254

Review 9.  Do recent epidemiologic observations impact who and how we should screen for CRC?

Authors:  Ethan Bortniker; Joseph C Anderson
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

10.  A Perturbation Method for Inference on Regularized Regression Estimates.

Authors:  Jessica Minnier; Lu Tian; Tianxi Cai
Journal:  J Am Stat Assoc       Date:  2012-01-24       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.